🇺🇸 FDA

Intelligence · Patent portfolio

Takeda Patents

Full USPTO pharma patent portfolio for Takeda — grant dates, expiration, and drug cross-links.

Patents
1,436
Expiring ≤24m
81

Quick answer

Takeda has 1,436 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 81 expire within 24 months — use filters for patent-cliff planning.

Page 19 of 30

  1. US 8273751

    Organic compounds

    Expires Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8273741

    Imidazo-pyridazinyl compounds and uses thereof

    Expires Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8268819

    Hexahydrooxazinopterine compounds

    Expires Mon Sep 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8263121

    Solid pharmaceutical preparation

    Expires Mon Sep 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8258252

    Sustained-release composition and process for producing the same

    Expires Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8252814

    Agents and crystals for improving excretory potency of urinary bladder

    Expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8246987

    Controlled release composition and method of producing the same

    Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8247403

    Benzoxazepine derivatives and use thereof

    Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8247429

    Tricyclic compound and pharmaceutical use thereof

    Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8236837

    Tricyclic compound and pharmaceutical use thereof

    Expires Mon Aug 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8222411

    Dipeptidyl peptidase inhibitors

    Expires Mon Jul 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8222422

    Crystal of benzimidazole compound

    Expires Mon Jul 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8217176

    Fused heterocyclic derivative and use thereof

    Expires Mon Jul 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8212046

    Process for producing crystal

    Expires Mon Jun 28 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8202990

    Polo-like kinase inhibitors

    Expires Mon Jun 14 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8188275

    Dipeptidyl peptidase inhibitors

    Expires Mon May 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8183212

    Compound having GPR54 agonistic activity

    Expires Mon May 17 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8183285

    Therapeutic agent for irritable bowel syndrome and methods thereof

    Expires Mon May 17 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8178543

    Bi- and tricyclic fused pyrimidines as tyrosine kinase inhibitors

    Expires Mon May 10 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8178555

    Apoptosis signal-regulating kinase 1 inhibitors

    Expires Mon May 10 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8178534

    cMET inhibitors

    Expires Mon May 10 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8173158

    Methods of treating gastrointestinal disorders independent of the intake of food

    Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8173663

    Dipeptidyl peptidase inhibitors

    Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8173645

    Glucokinase activators

    Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8173360

    Cell death inhibitor

    Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8163779

    Glucokinase activators

    Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8163935

    Fused heterocyclic compounds

    Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8163755

    Hexahydrooxazinopterine compounds

    Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8158617

    Fused heterocyclic compound and use thereof

    Expires Mon Apr 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8153694

    Cyclopropanecarboxylic acid compound

    Expires Mon Apr 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8148367

    Renin inhibitors

    Expires Mon Mar 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8143258

    Benzothiazole compounds useful for Raf inhibition

    Expires Mon Mar 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8133898

    Renin inhibitors

    Expires Mon Mar 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8124617

    Imidazopyridine compounds

    Expires Mon Feb 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 8124606

    Substituted 7,8,9,10-tetrahydro-5H-dipyrido[1,2-a:3′,2′-e]pyrazin-6(6aH)-ones

    Expires Mon Feb 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 8119655

    Kinase inhibitors

    Expires Mon Feb 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 8114620

    Diagnostic and therapeutic target PRKX proteins for neurodegenerative diseases

    Expires Mon Feb 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 8110585

    Bicyclic compound and pharmaceutical use thereof

    Expires Mon Feb 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 8105626

    Granules containing acid-unstable chemical in large amount

    Expires Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8097737

    Process for production of optically active amine derivatives

    Expires Mon Jan 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8092830

    Lactic acid polymer and process for producing the same

    Expires Mon Jan 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 8093236

    Weekly administration of dipeptidyl peptidase inhibitors

    Expires Mon Jan 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8093403

    Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same

    Expires Mon Jan 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 8093382

    Dipeptidyl peptidase inhibitors

    Expires Mon Jan 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 8088726

    Process for producing sustained-release composition

    Expires Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8088821

    Fused cyclic compounds

    Expires Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 8084058

    Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative

    Expires Mon Dec 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 8071766

    HSP90 inhibitors

    Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Takeda have?

1,436 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Takeda patents expire?

81 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.